NCT05587699 - The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

September 15, 2023

Study Completion Date

October 17, 2023

Conditions

Alopecia

Interventions

DRUG

CKD-843 A 45mg(Multiple dose)

1 Injection/3 Month, 3 times Injections

DRUG

CKD-843 A 45mg

Single Injection

DRUG

CKD-843 A 55mg(Multiple dose)

1 Injection/3 Month, 3 times Injections

DRUG

CKD-843 A 55mg

Single Injection

DRUG

CKD-843-R

0.5mg/day, 9 Month

Trial Locations (1)

Severance Hospital, Seoul